Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Mike M who wrote (1440)	11/5/1999 11:05:00 PM
From: Hank	Read Replies (1) \| Respond to of 5582

"...they may have to hold off advertisement because they are struggling to meet demand ..." Wow. Mike, have you ever thought of becoming a professional comedian? You got the gift man!

To: Mike M who wrote (1440)	11/5/1999 11:15:00 PM
From: Mark Marcellus	Read Replies (2) \| Respond to of 5582

One thing is pretty certain. AJIC is not likely to publish the second clinical. (That clinical is not yet complete by the way). In fact, the officer I talked to seemed to wonder if the results would be presented to medical journals or simply announced.... No need for peer review or journals eh? Management of this company has such integrity that we can just take them on their word that studies show that Zicam is the greatest thing since COLD-EEZE. And so many people were sure that a journal article was going to be published. I'm just shocked, shocked that it may not happen.